£11m float a-Hoy for sports nutrition firm

A SPORTS nutrition firm whose products have helped top athletes including Olympic cycling hero Sir Chris Hoy is shaping up for Aim.

SiS ambassador Sir Chris Hoy

Science in Sport (SiS) is being spun out of another Aim company, Provexis, as a standalone business with an expected market value of about £11million.

Advertisement

Medical foods and dietary supplements business Provexis reckons the value of Science in Sport, which it acquired two years ago, will not be fully appreciated while it is combined with its Fruitflow anti-thrombotic technology.

It believes both arms will have a better chance of fulfilling their potential by going it alone.

Provexis investors will remain shareholders in both businesses.

Get personal finance news, money saving tips and advice plus selcted offers and competitions
Invalid email Invalid email

You agree you are 18 or over. We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and third parties based on our knowledge of you. You can unsubscribe at any time. More Info.

Sir Chris, who has used the company’s products for many years, signed up as a brand ambassador for Science in Sport earlier this year.

The firm has also recently launched an AskHoy.com website, where athletes can get personalised information on sports nutrition.

Advertisement
__BREAK1RIGHT__

The company’s products, which are stocked by major retailers such as Tesco and Sainsbury’s, include the isotonic gel SiS Go Gel, as well as hydration powders and tablets, food bars and recovery powders.

It is the official supplier of sports drinks and nutrition to the GB Rowing Team.

In the year to the end of March, the company made an underlying operating profit of £100,000 on sales of £5.5million – an 11 per cent increase in turnover on the previous year.

Advertisement

It is led by chief executive Stephen Moon, formerly worldwide business development ­director for GlaxoSmithKline’s nutritional healthcare business.

SiS intends to use the £1.7million proceeds from the placing to boost its working capital, as ­revenues grow, and for factory investment.

It believes joining Aim will raise its market profile, help it recruit and retain skilled staff and provide potential spending firepower for further growth.

__RELATEDPOSTS__

PREMIUM ARTICLES

NEWS

POLITICS

ROYAL

SHOWBIZ & TV

SPORT

FINANCE

TRAVEL

LIFE & STYLE

F1

TENNIS